danazol has been researched along with methylprednisolone in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Berchtold, P; McMillan, R | 1 |
| Kodera, Y; Kojima, S; Matsushita, T; Minami, S; Miyamura, K; Takeyama, K | 1 |
| Lilleyman, JS | 1 |
| Arimura, K; Higuchi, I; Izumo, S; Kawabata, M; Kubota, H; Maruyama, Y; Nakagawa, M; Nakahara, K; Osame, M | 1 |
| Chin, M; Harada, K; Kojima, S; Mugishima, H; Ryo, S; Shichino, H; Shimada, T; Suzuki, T; Takamura, M | 1 |
| Bolognesi, S; Castiglioni, MG; Mechelli, S; Siuti, E; Stefanelli, A | 1 |
| Arnal, C; Bierling, P; Godeau, B; Hachulla, E; Léone, J; Papo, T; Piette, JC; Roudot-Thoraval, F; Schaeffer, A; Taillan, B | 1 |
| Gadsden, JC; Wong, DT | 1 |
| Boruchov, DM; Bussel, JB; Driscoll, MC; Gururangan, S | 1 |
| Akay, OM; Andic, N; Gunduz, E; Şahin, D; Teke, HÜ | 1 |
| Hao, J; Wang, T | 1 |
2 review(s) available for danazol and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapy of chronic idiopathic thrombocytopenic purpura in adults.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Ascorbic Acid; Autoimmune Diseases; Azathioprine; Colchicine; Cyclophosphamide; Cyclosporins; Danazol; Female; gamma-Globulins; Humans; Methylprednisolone; Plasmapheresis; Platelet Transfusion; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombocytopenic; Splenectomy; Vinca Alkaloids | 1989 |
3 trial(s) available for danazol and methylprednisolone
| Article | Year |
|---|---|
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antiviral Agents; Ascorbic Acid; Azathioprine; Danazol; Erythromycin; Estrogen Antagonists; Female; Fosfomycin; Glycerol; Human T-lymphotropic virus 1; Humans; Hydrocortisone; Immunoglobulins, Intravenous; Immunosuppressive Agents; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Interferon-gamma; Leukapheresis; Male; Methylprednisolone; Middle Aged; Paraparesis, Tropical Spastic; Pentoxifylline; Plasmapheresis; Propiophenones; Respiratory Therapy; Ribonucleosides; Sulfasalazine; Thyrotropin-Releasing Hormone; Vasodilator Agents | 1996 |
Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Danazol; Drug Administration Routes; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Retrospective Studies; Splenectomy; Treatment Outcome | 2002 |
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Child; Child, Preschool; Danazol; Drug Administration Routes; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Time Factors; Treatment Failure | 2007 |
14 other study(ies) available for danazol and methylprednisolone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Severe aplastic anemia remarkably improved by a treatment with antilymphocyte globulin, high-dose methylprednisolone and danazol].
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Danazol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Methylprednisolone; Pregnadienes | 1989 |
Idiopathic thrombocytopenic purpura--where do we stand?
Topics: Child; Child, Preschool; Danazol; Hemorrhage; Humans; Methylprednisolone; Prognosis; Purpura, Thrombocytopenic; Splenectomy | 1984 |
Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazol and recombinant human granulocyte-colony stimulating factor.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Danazol; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Recombinant Proteins | 1996 |
[Methimazole-induced aplastic anemia].
Topics: Adult; Aged; Anemia, Aplastic; Anti-Inflammatory Agents; Antithyroid Agents; Danazol; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Hyperthyroidism; Immunoglobulins, Intravenous; Male; Methimazole; Methylprednisolone; Middle Aged; Time Factors | 1999 |
Acute upper airway angioedema secondary to acquired C1 esterase inhibitor deficiency: a case report.
Topics: Acute Disease; Airway Obstruction; Anesthetics, Local; Angioedema; Anti-Inflammatory Agents; Bronchodilator Agents; Carticaine; Complement C1 Inactivator Proteins; Danazol; Diagnosis, Differential; Diphenhydramine; Epinephrine; Estrogen Antagonists; Female; Humans; Intubation, Intratracheal; Methylprednisolone; Middle Aged; Respiratory System; Secondary Prevention | 2003 |
Cardiac and pulmonary thrombosis during multidrug treatment in an idiopathic thrombocytopenic purpura patient.
Topics: Adult; Benzoates; Danazol; Female; Humans; Hydrazines; Immunoglobulins, Intravenous; Methylprednisolone; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Venous Thrombosis; Vincristine | 2014 |
5-Aminolevulinic acid photodynamic therapy and isotretinoin for treatment of drug-induced acne fulminans in a patient with idiopathic thrombocytopenic purpura.
Topics: Acne Vulgaris; Administration, Oral; Adult; Aminolevulinic Acid; Danazol; Drug Therapy, Combination; Estrogen Antagonists; Glucocorticoids; Humans; Isotretinoin; Male; Methylprednisolone; Photochemotherapy; Photosensitizing Agents; Purpura, Thrombocytopenic, Idiopathic | 2020 |